Human Mesenchymal Stem Cells (hMSC) Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC0912887
Human Mesenchymal Stem Cells (hMSC) MarketBy Product Type (Umbilical Cord Matrix hMSC, Bone Marrow hMSC, Adipose Tissue hMSC, Other) and Application (Medical Application, Research, Other Applications)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Human Mesenchymal Stem Cells (hMSC) Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Human Mesenchymal Stem Cells (hMSC) areused to treat bone and cartilage diseases and play a very critical role in the marrow microenvironment.These human mesenchymal stem cells are an essential component of the stromal scaffold of the bone marrow that provides physical and functional support during hematopoiesis.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Human Mesenchymal Stem Cells (hMSC) Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- PromoCell
- ThermoFisher
- KURABO
- Lifeline Cell Technology
- Merck
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Human Mesenchymal Stem Cells (hMSC) Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Umbilical Cord Matrix hMSC
o Bone Marrow hMSC
o Adipose Tissue hMSC
o Other
· Human Mesenchymal Stem Cells (hMSC) Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Medical Application
o Research
o Other Applications
· Human Mesenchymal Stem Cells (hMSC) Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o PromoCell
o ThermoFisher
o KURABO
o Lifeline Cell Technology
o Merck
· Human Mesenchymal Stem Cells (hMSC) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Human Mesenchymal Stem Cells (hMSC) Market , By Country
o U.S. Human Mesenchymal Stem Cells (hMSC) Market
o Canada Human Mesenchymal Stem Cells (hMSC) Market
o Mexico Human Mesenchymal Stem Cells (hMSC) Market
o Europe
§ Europe Human Mesenchymal Stem Cells (hMSC) Market , By Country
o UK Human Mesenchymal Stem Cells (hMSC) Market
o Germany Human Mesenchymal Stem Cells (hMSC) Market
o France Human Mesenchymal Stem Cells (hMSC) Market
o Russia Human Mesenchymal Stem Cells (hMSC) Market
o Italy Human Mesenchymal Stem Cells (hMSC) Market
o Rest of Europe Human Mesenchymal Stem Cells (hMSC) Market
o Asia-Pacific
§ Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market , By Country
o China Human Mesenchymal Stem Cells (hMSC) Market
o Japan Human Mesenchymal Stem Cells (hMSC) Market
o South Korea Human Mesenchymal Stem Cells (hMSC) Market
o India Human Mesenchymal Stem Cells (hMSC) Market
o Southeast Asia Human Mesenchymal Stem Cells (hMSC) Market
o Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market
o South America
§ South America Human Mesenchymal Stem Cells (hMSC) Market
o Brazil Human Mesenchymal Stem Cells (hMSC) Market
o Argentina Human Mesenchymal Stem Cells (hMSC) Market
o Columbia Human Mesenchymal Stem Cells (hMSC) Market
o Rest of South America Human Mesenchymal Stem Cells (hMSC) Market
o Middle East and Africa
§ Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Market
o Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Market
o UAE Human Mesenchymal Stem Cells (hMSC) Market
o Egypt Human Mesenchymal Stem Cells (hMSC) Market
o Nigeria Human Mesenchymal Stem Cells (hMSC) Market
o South Africa Human Mesenchymal Stem Cells (hMSC) Market
o TurkeyHuman Mesenchymal Stem Cells (hMSC) Market
o Rest of MEA Human Mesenchymal Stem Cells (hMSC) Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Human Mesenchymal Stem Cells (hMSC) Market, By Product Type
5.1. Introduction
5.2. Global Human Mesenchymal Stem Cells (hMSC) Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Human Mesenchymal Stem Cells (hMSC) Revenue and Revenue Share by Product Type (2017-2021)
5.3. Umbilical Cord Matrix hMSC
5.3.1. Global Umbilical Cord Matrix hMSC Revenue and Growth Rate (2017-2021)
5.4. Bone Marrow hMSC
5.4.1. Global Bone Marrow hMSC Revenue and Growth Rate (2017-2021)
5.5. Adipose Tissue hMSC
5.5.1. Global Adipose Tissue hMSC Revenue and Growth Rate (2017-2021)
5.6. Other
5.6.1. Global Other Revenue and Growth Rate (2017-2021)
6. Human Mesenchymal Stem Cells (hMSC) Market, By Applications
6.1. Introduction
6.2. Global Human Mesenchymal Stem Cells (hMSC) Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Human Mesenchymal Stem Cells (hMSC) Revenue and Revenue Share by Applications (2017-2021)
6.3. Medical Application
6.3.1. Global Medical Application Revenue and Growth Rate (2017-2021)
6.4. Research
6.4.1. Global Research Revenue and Growth Rate (2017-2021)
6.5. Other Applications
6.5.1. Global Other Applications Revenue and Growth Rate (2017-2021)
7. Human Mesenchymal Stem Cells (hMSC) Market, By Region
7.1. Introduction
7.2. Global Human Mesenchymal Stem Cells (hMSC) Revenue and Market Share by Regions
7.2.1. Global Human Mesenchymal Stem Cells (hMSC) Revenue by Regions (2017-2021)
7.3. North America Human Mesenchymal Stem Cells (hMSC) by Countries
7.3.1. North America Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2021)
7.3.2. North America Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Human Mesenchymal Stem Cells (hMSC) by Countries
7.4.1. Europe Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2021)
7.4.2. Europe Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Human Mesenchymal Stem Cells (hMSC) by Countries
7.5.1. Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Human Mesenchymal Stem Cells (hMSC) by Countries
7.6.1. South America Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2021)
7.6.2. South America Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Human Mesenchymal Stem Cells (hMSC) by Countries
7.7.1. Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. PromoCell
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. ThermoFisher
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. KURABO
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Lifeline Cell Technology
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Merck
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.1. Global Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Human Mesenchymal Stem Cells (hMSC) Market Forecast by Regions (2022-2027)
9.2.1. North America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.1.1. United States Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.1.2. Canada Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.1.3. Mexico Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2. Europe Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.1. Germany Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.2. France Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.3. UK Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.4. Russia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.5. Italy Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3. Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.1. China Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.2. Japan Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.3. Korea Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.4. India Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.4. South America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.4.1. Brazil Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.4.2. Argentina Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.4.3. Columbia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.4.4. Rest of South America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5. Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.3. Egypt Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.4. Nigeria Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.5. South Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.6. Turkey Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2022-2027)
9.3. Human Mesenchymal Stem Cells (hMSC) Market Forecast by Product Type (2022-2027)
9.3.1. Human Mesenchymal Stem Cells (hMSC) Forecast by Product Type (2022-2027)
9.3.2. Human Mesenchymal Stem Cells (hMSC) Market Share Forecast by Product Type (2022-2027)
9.4. Human Mesenchymal Stem Cells (hMSC) Market Forecast by Applications (2022-2027)
9.4.1. Human Mesenchymal Stem Cells (hMSC) Forecast by Applications (2022-2027)
9.4.2. Human Mesenchymal Stem Cells (hMSC) Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Human Mesenchymal Stem Cells (hMSC) Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Umbilical Cord Matrix hMSC Revenue and Growth Rate (2017-2019)
Figure Global Bone Marrow hMSC Revenue and Growth Rate (2017-2019)
Figure Global Adipose Tissue hMSC Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Human Mesenchymal Stem Cells (hMSC) Revenue and Revenue Share by Applications (2017-2019)
Figure Global Medical Application Revenue and Growth Rate (2017-2019)
Figure Global Research Revenue and Growth Rate (2017-2019)
Figure Global Other Applications Revenue and Growth Rate (2017-2019)
Table Global Human Mesenchymal Stem Cells (hMSC) Revenue by Regions (2017-2019)
Figure North America Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure North America Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2019)
Figure North America Human Mesenchymal Stem Cells (hMSC) by Countries (2017-2019)
Figure North America Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2019)
Figure United States Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure United States Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Canada Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Mexico Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Europe Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2019)
Figure Europe Human Mesenchymal Stem Cells (hMSC) by Countries (2017-2019)
Figure Europe Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2019)
Figure Germany Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Germany Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure France Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure UK Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Russia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Italy Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Rest of Europe Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Human Mesenchymal Stem Cells (hMSC) by Countries (2017-2019)
Figure Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2019)
Figure China Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure China Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Japan Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Korea Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure India Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Southeast Asia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure South America Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2019)
Figure South America Human Mesenchymal Stem Cells (hMSC) by Countries (2017-2019)
Figure South America Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Brazil Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Argentina Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Columbia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Rest of South America Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Human Mesenchymal Stem Cells (hMSC) by Countries (2017-2019)
Figure Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Egypt Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Nigeria Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure South Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Turkey Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2017-2019)
Table PromoCell Human Mesenchymal Stem Cells (hMSC) Financial Overview
Table ThermoFisher Human Mesenchymal Stem Cells (hMSC) Financial Overview
Table KURABO Human Mesenchymal Stem Cells (hMSC) Financial Overview
Table Lifeline Cell Technology Human Mesenchymal Stem Cells (hMSC) Financial Overview
Table Merck Human Mesenchymal Stem Cells (hMSC) Financial Overview
Figure Global Human Mesenchymal Stem Cells (hMSC) Revenue (Millions USD) and Growth Rate (2019-2027)
Table Human Mesenchymal Stem Cells (hMSC) Market Forecast by Regions (2019-2027)
Figure North America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure United States Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Canada Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Mexico Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Europe Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Germany Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure France Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure UK Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Russia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Italy Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Rest of Europe Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure China Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Japan Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Korea Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure India Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Southeast Asia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure South America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Brazil Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Argentina Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Columbia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Rest of South America Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Saudi Arabia Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure United Arab Emirates Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Egypt Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Nigeria Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure South Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Turkey Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Human Mesenchymal Stem Cells (hMSC) Market Forecast (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Forecast by Product Type (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Market Share Forecast by Product Type (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Forecast by Product Type (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Forecast by Applications (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Market Share Forecast by Applications (2019-2027)
Figure Global Human Mesenchymal Stem Cells (hMSC) Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|